The DOI matches its Crossref record.
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease
Abstract
The distribution of neurofibrillary tangles (NFTs) and neuritic plaques (NPs) was mapped in 39 cortical areas of 11 brains of patients with Alzheimer's disease (AD). Whole hemisphere blocks were embedded in polyethylene glycol (Carbowax), sectioned coronally, and stained with thioflavin S and thionin. The densities of NFTs and NPs were assessed using a numerical rating scale for each area. Scores were grouped by type of cortex and by lobe for statistical analysis. Highly significant differences were obtained. For example, limbic periallocortex and allocortex had more NFTs than any other type of cortex. In descending order, the density of NFTs was as follows: periallocortex (area 28) greater than allocortex (subiculum/CA1 zones of hippocampal formation, area 51) greater than corticoid areas (accessory basal nucleus of amygdala, nucleus basalis of Meynert) greater than proisocortex (areas 11, 12, 24, 23, anterior insula, 38, 35) greater than nonprimary association cortex (32, 46, superior temporal sulcus, 40, 39, posterior parahippocampal cortex, 37, 36) greater than primary sensory association cortex (7, 18, 19, 22, 21, 20) greater than agranular cortex (44-5, 8, 6, 4) greater than primary sensory cortex (41-2, 3-1-2, 17). The laminar distribution of NFTs tended to be selective, involving primarily layers III and V of association areas and layers II and IV of limbic periallocortex. There were far more NFTs in both limbic and temporal lobes than in frontal, parietal, and occipital lobes. In general, NPs were more evenly distributed throughout the cortex, with the exceptions of limbic periallocortex and allocortex, which had notably fewer NPs than other cortical areas. Temporal and occipital lobes had the highest NP densities, limbic and frontal lobes had the lowest, and parietal lobe was intermediate. No significant left-right hemispheric differences for NFT or NP densities were found across the population, and there was no relationship between duration of illness and densities of NFTs or NPs. The regional and laminar distribution of NFTs (and, to a lesser degree, that of NPs) suggests a consistent pattern of vulnerability within the cerebral cortices that seems correlated to the hierarchies of cortico-cortical connections. The higher-order association cortices, especially those in the anterior and ventromedial sectors of temporal lobe, are the most vulnerable, while other cortices appear less vulnerable to a degree commensurate with their connectional "distance" (i.e., synapses removed) from the limbic areas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The EC is affected severely in Alzheimer disease (AD), likely contributing to memory impairment.”
From Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996) · cites this paper as Arnold et al., 1991
In the citing paper
“The EC was chosen because it is highly selectively vulnerable in AD (Hyman et al., 1984(Hyman et al., , 1986;;Arnold et al., 1991;Braak and Braak, 1991;Price et al., 1991;Arriagada et al., 1992a;Fukutani et al., 1995;Solodkin and Van Hoesen, 1996).”
From Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996) · cites this paper as Arnold et al., 1991
In the citing paper
“The midfrontal gyrus cortex (corresponding predominantly to Brodmann area 46) was chosen for semi-quantitative image analyses of AD pathology, cellular and synaptic markers because of its important role in complex cognition and its common neuropathological involvement in the spectrum of AD (Arnold, et al., 1991).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Arnold, et al., 1991
In the citing paper
“as this region is the first area of the brain involved by the neurofibrillary pathology of AD(4, 5).”
From Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (2000) · cites this paper as [5]
In the citing paper
“We consider it to be an important clue that most brains from elderly human subjects show abnormalities that fall somewhere along particular continua of pathologic severity (60, 96-100).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [100]
In the citing paper
“In the early stages of Alzheimer’s disease (AD), the most common form of age-related dementia, clinical symptoms (such as memory loss) are caused by the selective degeneration of principal neurons of the entorhinal cortex layer II (ECII), followed by CA1 pyramidal cells in the hippocampus, and pyramidal neurons in neocortical association areas.”
From Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis (2020) · cites this paper as Arnold et al., 1991
In the citing paper
“In contrast, other brain regions, such as the primary sensory cortices, are relatively resistant to degeneration until later stages of the disease (Arnold et al., 1991; Bussière et al., 2003; Fukutani et al., 2000; Gómez-Isla et al., 1996; Hof and Morrison, 1990; Hyman et al., 1984; Morrison and Hof, 1997; West et al., 1994).”
From Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis (2020) · cites this paper as Arnold et al., 1991
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 501–600 of 1,002
Diagnosis and Staging of Alzheimer Disease
Duyckaerts, C. J., & Hauw, J. J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00067-5 · Cited by 65
Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort
Miller, M. I., Laurent Younes, B., Ratnanather, J. T., Brown, T., Trinh, H., Lee, D. S., Tward, D. J., Mahon, P. B., Mori, S., & Albert, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.032 · Cited by 64
Quantitative EEG Markers in Mild Cognitive Impairment: Degenerative versus Vascular Brain Impairment
Moretti, D. V., Zanetti, O. O., Binetti, G. G., & Frisoni, G. B. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/917537 · Cited by 64
Postle, B. R., & Corkin, S. (1998) · Neuropsychologia · doi:10.1016/s0028-3932(97)00155-3 · Cited by 64
Kaufer, D. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051193 · Cited by 64
Neuropathologic Correlates of Activities of Daily Living in Alzheimer Disease
Marshall, G. A., Fairbanks, L. A., Tekin, S., Vinters, H. V., & Cummings, J. L. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201852.60330.16 · Cited by 64
Sensitivity to ageing of the limbic dopaminergic system: a review
Barili, P., Carolis, G. D., Zaccheo, D., & Amenta, F. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00104-3 · Cited by 68
I: Longitudinal changes in aging brain function
Beason-Held, L. L., Kraut, M. A., & Resnick, S. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.031 · Cited by 63
Inadequate inhibition of redundant auditory inputs in Alzheimer's disease: An MEG study
Cheng, C., Wang, P., Hsu, W., & Lin, Y. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.11.010 · Cited by 63
Brain glucose and ketone utilization in brain aging and neurodegenerative diseases
Kapogiannis, D., & Avgerinos, K. I. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.015 · Cited by 64
Olfactory Identification in Elderly Schizophrenia and Alzheimer’s Disease
Moberg, P. J., Doty, R. L., Mahr, R. N., Mesholam, R. I., Arnold, S. E., Turetsky, B. I., & Gur, R. E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00015-8 · Cited by 63
Self-citationFan, L., Tzen, K., Chen, Y., Chen, T., Lai, Y., Yen, R., Huang, Y.-Y., Shiue, C., Yang, S., & Chiu, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00175 · Cited by 64
Gong, N., Chan, C., Leung, L., Wong, C.-S., Dibb, R., & Liu, C. (2017) · Human Brain Mapping · doi:10.1002/hbm.23535 · Cited by 62
Olfactory-evoked regional cerebral blood flow in Alzheimer's disease.
Kareken, D. A., Doty, R. L., Moberg, P. J., Mosnik, D. M., Chen, S. A., Farlow, M. R., & Hutchins, G. D. (2001) · Neuropsychology · doi:10.1037//0894-4105.15.1.18 · Cited by 62
Early Intervention Is Key to Successful Management of Alzheimer Disease
DeKosky, S. T. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307004-00004 · Cited by 63
Allocortical neurofibrillary changes in progressive supranuclear palsy
Braak, H., Jellinger, K. A., Braak, E., & Böhl, J. (1992) · Acta Neuropathologica · doi:10.1007/bf00304466 · Cited by 62
Arnold, S. E., Toledo, J. B., Appleby, D. H., Xie, S. X., Wang, W., Baek, Y., Wolk, D. A., Lee, E. B., Miller, B. L., Lee, V. M. ‐., et al. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23430 · Cited by 66
Self-citationHeterogeneity of semantic and visuospatial deficits in early Alzheimer's disease.
Caine, D., & Hodges, J. R. (2001) · Neuropsychology · doi:10.1037/0894-4105.15.2.155 · Cited by 61
Pietrini, P., Alexander, G. E., Furey, M. L., Hampel, H. J., & Guazzelli, M. (2000) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(00)00097-0 · Cited by 62
Visual search in Alzheimer’s disease: a deficiency in processing conjunctions of features
Tales, A., Butler, S. R., Fossey, J., Gilchrist, I. D., Jones, R. W., & Troscianko, T. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(02)00073-8 · Cited by 61
Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia
Iráizoz, I., Guijarro, J. L., Gonzalo, L. M., & Lacalle, S. D. (1999) · Acta Neuropathologica · doi:10.1007/s004010051068 · Cited by 61
Giannakopoulos, P., Hof, P. R., Surini, M., Michel, J., & Bouras, C. (1993) · Acta Neuropathologica · doi:10.1007/bf00334669 · Cited by 61
Fiala, J. C., Feinberg, M. D., Peters, A., & Barbas, H. (2007) · Brain Structure and Function · doi:10.1007/s00429-007-0153-1 · Cited by 64
Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
Willuweit, A., Velden, J., Godemann, R., Manook, A., Jetzek, F., Tintrup, H., Kauselmann, G., Zevnik, B., Henriksen, G., Drzezga, A. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007931 · Cited by 60
Negative Symptoms in Patients With Alzheimer's Disease
GALYNKER, I. I., Roane, D. M., Miner, C. R., Feinberg, T. E., & Watts, P. (1995) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199524310-00007 · Cited by 60
Bayer, T. A., & Wirths, O. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00372.x · Cited by 60
Distinct mechanisms of impairment in cognitive ageing and Alzheimer's disease
Mapstone, M. E., Dickerson, K., & Duffy, C. J. (2008) · Brain · doi:10.1093/brain/awn064 · Cited by 59
Mouse Genetic Models of Human Brain Disorders
Leung, C., & Jia, Z. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00040 · Cited by 63
Olfactory dysfunction occurs in transgenic mice overexpressing human τ protein
Macknin, J. B., Higuchi, M., Lee, V. M. ‐., Trojanowski, J. Q., & Doty, R. L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.047 · Cited by 60
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
Desikan, R. S., Thompson, W. K., Holland, D., Hess, C. P., Brewer, J. B., Zetterberg, H., Blennow, K., Andreassen, O. A., McEvoy, L. K., Hyman, B. T., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-39 · Cited by 59
Self-citationThe Merits of FDDNP-PET Imaging in Alzheimer's Disease
Shin, J., Kepe, V., Barrio, J. R., & Small, G. W. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0008 · Cited by 62
Pathologic Correlates of Apraxia in Alzheimer Disease
Giannakopoulos, P., Duc, M., Gold, G., Hof, P. R., Michel, J., & Bouras, C. (1998) · Archives of Neurology · doi:10.1001/archneur.55.5.689 · Cited by 58
Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions
Arnold, S. E., Franz, B. R., & Trojanowski, J. Q. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90024-8 · Cited by 58
Self-citationNMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex
Carlson, M. D., Penney, J. B., & Young, A. B. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90120-z · Cited by 58
Practical measures to simplify the Braak tangle staging method for routine pathological screening
Harding, A. J., Kril, J. J., & Halliday, G. M. (2000) · Acta Neuropathologica · doi:10.1007/pl00007425 · Cited by 58
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
Villemagne, V. L., Klunk, W. E., Mathis, C. A., Rowe, C. C., Brooks, D. J., Hyman, B. T., Ikonomović, M. D., Ishii, K., Jack, C. R., Jagust, W. J., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2045-0 · Cited by 58
Self-citationRegulation of Caspases in the Nervous System
Troy, C. M., Akpan, N., & Jean, Y. Y. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385504-6.00007-5 · Cited by 58
Waragai, M., Okamura, N., Furukawa, K., Tashiro, M., Furumoto, S., Funaki, Y., Kato, M., Iwata, R., Yanai, K., Kudo, Y., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.06.005 · Cited by 59
Demyelination in Mild Cognitive Impairment Suggests Progression Path to Alzheimer’s Disease
Carmeli, C., Donati, A., Antille, V., Viceic, D., Ghika, J. A., von Gunten, A., Clarke, S., Meuli, R. A., Frackowiak, R. S. J., & Knyazeva, M. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072759 · Cited by 57
Comparative semantic profiles in semantic dementia and Alzheimer’s disease
Libon, D. J., Rascovsky, K., Powers, J., Irwin, D. J., Boller, A., Weinberg, D. D., McMillan, C. T., & Grossman, M. (2013) · Brain · doi:10.1093/brain/awt165 · Cited by 59
Progression of Seed‐Induced A β Deposition within the Limbic Connectome
Ye, L., Hamaguchi, T., Fritschi, S. K., Eisele, Y. S., Obermüller, U., Jucker, M., & Walker, L. C. (2015) · Brain Pathology · doi:10.1111/bpa.12252 · Cited by 60
Blanken, A. E., Hurtz, S., Zarow, C., Biado, K., Honarpisheh, H., Somme, J. H., Brook, J. K., Tung, S., Kraft, E., Lo, D. C. W., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.04.020 · Cited by 57
Miller, M. I., Hosakere, M., Barker, A. R., Priebe, C. E., Lee, N., Ratnanather, J. T., Wang, L., Gado, M., Morris, J. C., & Csernansky, J. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136624100 · Cited by 57
Terry, D. P., Sabatinelli, D., Puente, A. N., Lazar, N. A., & Miller, L. S. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12266 · Cited by 56
Lowndes, G., & Savage, G. R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9032-z · Cited by 56
Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology
Hahn, A., Schain, M., Erlandsson, M., Sjölin, P., James, G. M., Strandberg, O. T., Hägerström, D., Lanzenberger, R. R., Jögi, J., Olsson, T. G., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.174508 · Cited by 57
Brilliant, M., Elble, R. J., Ghobrial, M., & Struble, R. G. (1997) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1997.4198041.x · Cited by 56
Early Diagnosis of Alzheimer’s Disease
Daffner, K. R., & Scinto, L. F. M. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_1 · Cited by 56
Calculation impairment in neurodegenerative diseases.
Halpern, C. H., McMillan, C., Moore, P., Dennis, K., & Grossman, M. (2003) · Journal of Neurological Sciences · doi:10.1016/s0022-510x(02)00416-1 · Cited by 55
Vermersch, P., Delacourte, A., Javoy-Agid, F., Hauw, J., & Agid, Y. (1993) · Annals of Neurology · doi:10.1002/ana.410330506 · Cited by 56
Optical coherence tomography visualizes neurons in human entorhinal cortex
Magnain, C. V., Augustinack, J. C., Konukoğlu, E., Frosch, M. P., Sakadžić, S., Michaud, A., Garcia, N., Wedeen, V. J., Boas, D. A., & Fischl, B. R. (2015) · Neurophotonics · doi:10.1117/1.nph.2.1.015004 · Cited by 56
Neocortical Disconnectivity Disrupts Sensory Integration in Alzheimer's Disease.
Festa, E. K., Insler, R. Z., Salmon, D. P., Paxton, J. L., Hamilton, J. M., & Heindel, W. C. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.6.728 · Cited by 55
Walton, J. R. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/914947 · Cited by 56
Functional neuroanatomy of the encoding and retrieval processes of verbal episodic memory in MCI
Clément, F., Belleville, S., & Mellah, S. (2009) · Cortex · doi:10.1016/j.cortex.2009.07.003 · Cited by 57
Lemoine, L., Saint‐Aubert, L., Nennesmo, I., Gillberg, P., & Nordberg, A. K. (2017) · Scientific Reports · doi:10.1038/srep45496 · Cited by 55
Ohm, D. T., Fought, A. J., Martersteck, A., Coventry, C., Sridhar, J., Gefen, T. D., Weıntraub, S., Bigio, E. H., Mesulam, M. M., Rogalski, E. J., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12902 · Cited by 59
Alzheimer Disease: Functional Abnormalities in the Dorsal Visual Pathway
Bokde, A. L. W., Lopez‐Bayo, P., Born, C., Ewers, M., Meindl, T., Teipel, S. J., Faltraco, F., Reiser, M. F., Möller, H., & Hampel, H. J. (2009) · Radiology · doi:10.1148/radiol.2541090558 · Cited by 55
Comparability of the Clinical Diagnostic Criteria for Vascular Dementia: A Critical Review. Part I
Wiederkehr, S., Simard, M., Fortin, C., & van Reekum, R. (2008) · Journal of Neuropsychiatry · doi:10.1176/jnp.2008.20.2.150 · Cited by 56
Ventromedial temporal lobe anatomy, with comments on Alzheimer's disease and temporal injury
Hoesen, G. W. V. (1997) · Journal of Neuropsychiatry · doi:10.1176/jnp.9.3.331 · Cited by 55
Pietrini, P., Furey, M. L., Alexander, G. E., Mentis, M. J., Dani, A., Guazzelli, M., Rapoport, S. I., & Schapiro, M. B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.3.470 · Cited by 55
Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
Castellani, R. J., Zhu, X., Lee, H., Smith, M. A., & Perry, G. L. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031386 · Cited by 57
Sex differences in chronic stress responses and Alzheimer's disease
Yan, Y., Dominguez, S., Fisher, D. W., & Dong, H. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.03.002 · Cited by 56
Cortical biochemistry in MCI and Alzheimer disease
Forman, M. S., Mufson, E. J., Leurgans, S. E., Praticò, D., Joyce, S. C., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Neurology · doi:10.1212/01.wnl.0000256373.39415.b1 · Cited by 54
Monitoring of general knowledge: Evidence for preservation in early Alzheimer's disease
Bäckman, L., & Lipinska, B. (1993) · Neuropsychologia · doi:10.1016/0028-3932(93)90157-u · Cited by 54
Apolipoprotein E Genotype and Deposits of Aβ40 and Aβ42 in Alzheimer Disease
McNamara, M. J., Gómez‐Isla, T., & Hyman, B. T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.1001 · Cited by 55
Self-citationBallesteros, S., Avilés, J. M. R., Mayas, J., & Heller, M. A. (2008) · Experimental Brain Research · doi:10.1007/s00221-008-1441-6 · Cited by 53
Song, Z., Insel, P. S., Buckley, S. T., Yohannes, S., Mezher, A. F., Simonson, A., Wilkins, S., Tosun, D., Mueller, S. G., Kramer, J. H., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2092-14.2015 · Cited by 55
Conejero‐Goldberg, C., Hyde, T. M., Chen, S., Dreses‐Werringloer, U., Herman, M. M., Kleinman, J. E., Davies, P., & Goldberg, T. E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.57 · Cited by 56
Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker
van Rooden, S., Versluis, M. J., Liem, M. K., Milles, J., Maier, A. B., Oleksik, A. M., WEBB, A. G., van Buchem, M. A., & van der Grond, J. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.02.002 · Cited by 57
Koliatsos, V. E., Dawson, T. M., Kecojević, A., Zhou, Y., Wang, Y.-F., & Huang, K.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404364101 · Cited by 53
Structural and Functional Hippocampal Changes in Subjective Cognitive Decline From the Community
Liang, L., Zhao, L., Wei, Y., Mai, W., Duan, G., Su, J., Nong, X., Yu, B., Li, C., Mo, X., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00064 · Cited by 53
Sihver, W., Gillberg, P.-G., Svensson, A., & Nordberg, A. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00295-x · Cited by 53
Gambi, F., Reale, M., Iarlori, C., Salone, A., Toma, L., Paladini, C., Luca, G. D., Feliciani, C., Salvatore, M., Salerno, R. M., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125683.74595.2f · Cited by 53
Willingham, D. B., Peterson, E. W., Manning, C. A., & Brashear, H. R. (1997) · Neuropsychology · doi:10.1037//0894-4105.11.2.261 · Cited by 53
Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease
Joyce, J. N., Kaeger, C., Ryoo, H., & Goldsmith, S. K. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90199-u · Cited by 53
Gul, A., Bakht, J., & Mehmood, F. (2019) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.07.004 · Cited by 52
Neuropathology of Alzheimer's Disease
Gómez‐Isla, T., Spires‐Jones, T. L., de Calignon, A., & Hyman, B. T. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01222-5 · Cited by 55
Self-citationDickerson, B. C., Brickhouse, M. J., McGinnis, S. M., Wolk, D. A., & Initiative, A. D. N. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.007 · Cited by 55
Simultanagnosia as the Initial Sign of Degenerative Dementia
Graff‐Radford, N. R., Bolling, J. P., Earnest, F., Shuster, E. A., Caselli, R. J., & Brazis, P. W. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62267-8 · Cited by 52
Accuracy of early diagnosis and its impact on the management and course of Alzheimer’s disease
Chang, C. Y., & Silverman, D. H. S. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.1.63 · Cited by 54
On the metabolism of apolipoprotein E and the Alzheimer diseases
Roses, A. D. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90019-5 · Cited by 52
Moghbel, M. C., Saboury, B., Basu, S. K., Metzler, S. D., Torigian, D. A., Långström, B., & Alavi, A. A. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1960-4 · Cited by 53
Passive Alzheimer’s immunotherapy: A promising or uncertain option?
Høilund‐Carlsen, P. F., Revheim, M.-E. R., Costa, T., Alavi, A. A., Kepp, K. P., Sensi, S. L., Perry, G. L., Robakis, N. K. R. K., Barrio, J. R., & Vissel, B. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101996 · Cited by 53
Evolutional Aspects of Alzheimer's Disease Pathogenesis
Braak, H., & Tredici, K. D. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129029 · Cited by 54
Yamasaki, T., Muranaka, H., Kaseda, Y., Mimori, Y., & Tobimatsu, S. (2011) · Neurology Research International · doi:10.1155/2012/719056 · Cited by 54
Cai, K., Xu, H., Guan, H., Zhu, W., Jiang, J., Cui, Y. J., Zhang, J., Liu, T., & Wen, W. X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170875 · Cited by 51
Expression of hMTH1 in the hippocampi of control and Alzheimer's disease
Furuta, A., Iida, T., Nakabeppu, Y., & Iwaki, T. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00028 · Cited by 51
Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits
Olson, M. L., Olson, E. A., Qualls, J. H., Stratton, J. J., Harding, J. W., & Wright, J. W. (2004) · Peptides · doi:10.1016/j.peptides.2003.12.005 · Cited by 51
The Value of Transgenic Models for the Study of Neurodegenerative Diseases
Price, D. L., Wong, P. C., Markowska, A. L., Lee, M. K., THINAKAREN, G., Cleveland, D. W., Sisodia, S. S., & Borchelt, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06920.x · Cited by 52
Kang, J. M., Lee, S., Seo, S., Jeong, H. J., Woo, S., Lee, H., Lee, Y., Yeon, B. K., Shin, D. H., Park, K. H., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.008 · Cited by 50
Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?
Valdez-Gaxiola, C. A., Rosales-Leycegui, F., Gaxiola-Rubio, A., Moreno-Ortíz, J. M., & Figuera, L. E. (2024) · Diseases · doi:10.3390/diseases12060110 · Cited by 55
Miller, M. I., Ratnanather, J. T., Tward, D. J., Brown, T., Lee, D. S., Ketcha, M. D., Mori, K., Wang, M., Mori, S., Albert, M., et al. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00054 · Cited by 53
Tosun, D., Initiative1, T. A. D. N., Schuff, N. W., Shaw, L. M. J., Trojanowski, J. Q., & Weiner, M. W. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0006 · Cited by 51
Giménez‐Llort, L., Maté, I., Manassra, R., Vida, C., & la Fuente, M. D. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06639.x · Cited by 53
Willette, A. A., Calhoun, V. D., Egan, J. M., & Kapogiannis, D. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.08.005 · Cited by 52
Clinico-Pathological Correlations of the Most Common Neurodegenerative Dementias
Taipa, R. J. F., Pinho, J., & Pires, M. M. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00068 · Cited by 54
Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers
Quiroz, Y. T., Stern, C. E., Reiman, E. M., Brickhouse, M. J., Ruiz‐Rizzo, A. L., Sperling, R. A., Lopera, F. J., & Dickerson, B. C. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303299 · Cited by 50
Vacchi, E., Kaelin‐Lang, A., & Melli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145030 · Cited by 51
Quantifier comprehension in corticobasal degeneration
McMillan, C. T., Clark, R., Moore, P., & Grossman, M. (2006) · Brain and Cognition · doi:10.1016/j.bandc.2006.06.005 · Cited by 51
Vermersch, P., Frigard, B., & Delacourte, A. (1992) · Acta Neuropathologica · doi:10.1007/bf00304633 · Cited by 50
Metadata
- Authors
- Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W.
- Affiliations
- University of Iowa (US)
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-01-01
- Volume
- 1
- Issue
- 1
- Pages
- 103-116
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2029923284
- Cited by
- 1,380
- References
- 0
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 32 · 2023: 34 · 2022: 31 · 2021: 45 · 2020: 36 · 2019: 41 · 2018: 47 · 2017: 43 · 2016: 42 · 2015: 40 · 2014: 42 · 2013: 54 · 2012: 42
- FWCI
- 19.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cerebral Cortex (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (P019632)
- National Institute on Aging (AG-08487)
- National Institute of Neurological Disorders and Stroke (R01NS014944, NS-14944)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, neuritic plaques, cortical topography, neuroanatomy, allocortex, temporal lobe, occipital lobe, frontal lobe, parietal lobe, laminar distribution, thioflavin S, thionin, amygdala, nucleus basalis of Meynert
- MeSH terms
- Aged, Alzheimer Disease, Brain Mapping, Cerebral Cortex, Female, Histocytochemistry, Humans, Male, Middle Aged, Neurites, Tissue Embedding, Neurofibrillary Tangles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
